Dimitri Drone

Mr. Drone is a Managing Director and Co-Head of Houlihan Lokey’s Corporate Valuation Advisory Services practice as well as leader of the Pharmaceutical and Life Sciences (PLS) practice. He is also a member of the firm’s Financial and Valuation Advisory business leadership team. Mr. Drone is based in the firm’s New York office.

Prior to joining Houlihan Lokey, Mr. Drone was the global leader of PwC’s Deals business for the PLS sector for nearly a decade. 

Mr. Drone is a seasoned deal consultant with over 30 years of experience advising on hundreds of transactions representing billions of dollars in transaction value and/or capital. More specifically, he advises corporate and private equity clients on the structuring of complex M&A transactions, alliances, partnerships, and joint ventures, as well as minority investments, to address financial reporting, corporate finance, and valuation issues. In addition, Mr. Drone is a leading advisor within the valuation community on valuation principles, methodologies, and critical assumptions employed in various business enterprise, intangible asset, and security valuation exercises across the spectrum of life science industries, including pharmaceuticals, biotech, medical device, diagnostics, generics, consumer, animal health, healthcare services, contract manufacturers, and contract research organizations. His clients range from startup biotech and medical device companies to the largest global life science companies.

Mr. Drone holds a B.S. in Accounting from Bucknell University and an MBA in Finance and Economics from the University of Chicago. He is a Certified Public Accountant in New York and a CFA charterholder.